HK1186378A1 - A composition and use thereof in the treatment of anal rhagades - Google Patents
A composition and use thereof in the treatment of anal rhagadesInfo
- Publication number
- HK1186378A1 HK1186378A1 HK13113705.4A HK13113705A HK1186378A1 HK 1186378 A1 HK1186378 A1 HK 1186378A1 HK 13113705 A HK13113705 A HK 13113705A HK 1186378 A1 HK1186378 A1 HK 1186378A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- composition
- anal rhagades
- rhagades
- anal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2012/000027 WO2013114410A1 (fr) | 2012-01-30 | 2012-01-30 | Composition et utilisation de celle-ci dans le traitement de rhagades anales |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1186378A1 true HK1186378A1 (en) | 2014-03-14 |
Family
ID=46001672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13113705.4A HK1186378A1 (en) | 2012-01-30 | 2013-12-10 | A composition and use thereof in the treatment of anal rhagades |
Country Status (24)
Country | Link |
---|---|
US (1) | US9345747B2 (fr) |
EP (1) | EP2646039B1 (fr) |
JP (1) | JP5903505B2 (fr) |
KR (1) | KR101599447B1 (fr) |
CN (2) | CN109865000A (fr) |
AU (1) | AU2012368815B2 (fr) |
BR (1) | BR112014018850A8 (fr) |
CA (1) | CA2863369C (fr) |
DK (1) | DK2646039T3 (fr) |
ES (1) | ES2485490T3 (fr) |
HK (1) | HK1186378A1 (fr) |
HR (1) | HRP20140594T1 (fr) |
IL (1) | IL233875A (fr) |
IN (1) | IN2014MN01733A (fr) |
MX (1) | MX336204B (fr) |
PL (1) | PL2646039T3 (fr) |
RS (1) | RS53457B (fr) |
RU (1) | RU2580622C2 (fr) |
SA (1) | SA113340239B1 (fr) |
SG (1) | SG11201404413UA (fr) |
SI (1) | SI2646039T1 (fr) |
TW (1) | TWI495476B (fr) |
WO (1) | WO2013114410A1 (fr) |
ZA (1) | ZA201405208B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2932156A1 (fr) | 2013-12-24 | 2015-07-02 | The Procter & Gamble Company | Compositions cosmetiques et procedes permettant de procurer une penetration amelioree de principes actifs pour soin de la peau |
ITRM20150163A1 (it) * | 2015-04-17 | 2016-10-17 | Uniderm Farm S R L | Composizioni farmaceutiche per il trattamento delle ragadi anali |
US10117826B2 (en) | 2016-03-31 | 2018-11-06 | Peter Angia Pham | Bodily lubricating and moisturizing compositions containing plant mucilage |
US10835504B2 (en) | 2018-04-18 | 2020-11-17 | G&S Laboratories, Inc. | Compositions to treat anal itch |
WO2020022991A2 (fr) * | 2018-05-02 | 2020-01-30 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Compositions topiques contre les vergetures sur la peau |
RU2771015C2 (ru) * | 2020-09-25 | 2022-04-25 | Общество с ограниченной ответственностью "ФАРМКОММ" | Фармацевтическая композиция в виде мази для лечения геморроя |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622939A (en) * | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
ATE214266T1 (de) * | 1997-04-16 | 2002-03-15 | Cognis France Sa | Verwendung einer aus hibiskus-esculentus-samen extrahierten proteinfraktion in der kosmetik |
US6379719B1 (en) * | 1998-04-08 | 2002-04-30 | Laboratories Serobiologiques (Societe Anonyme) | Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction |
CN1233469A (zh) * | 1998-04-28 | 1999-11-03 | 王京杭 | 组织修复促进剂 |
JP2002204687A (ja) * | 2000-11-09 | 2002-07-23 | Onaka Yasushi | β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用 |
US6956120B2 (en) * | 2000-11-09 | 2005-10-18 | Yasushi Onaka | β-1.3-1.6 glucan (Aureobasidium medium) |
JP2003104832A (ja) * | 2001-09-28 | 2003-04-09 | Chifure Keshohin:Kk | 皮膚外用剤 |
JP4544500B2 (ja) * | 2002-07-19 | 2010-09-15 | 一丸ファルコス株式会社 | ヒアルロン酸合成促進剤 |
EP1622627B1 (fr) * | 2003-05-02 | 2013-05-22 | Ceapro Inc. | Compositions pharmaceutiques contenant un beta(1-3) beta(1-4) glucane de céréale |
RU2277920C2 (ru) * | 2004-02-24 | 2006-06-20 | Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" | Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой |
ITMI20042111A1 (it) * | 2004-11-04 | 2005-02-04 | Biofarmitalia Spa | Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia |
JP5048935B2 (ja) * | 2005-08-24 | 2012-10-17 | 株式会社ヤクルト本社 | 保湿剤 |
DE202007004856U1 (de) * | 2007-04-01 | 2007-06-06 | Rühle, Wilfried, Dipl.-Ing. | CHM Anti Aging Komplex |
CN101095482B (zh) * | 2007-07-05 | 2012-02-15 | 中国科学院长春应用化学研究所 | 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法 |
US20090202664A1 (en) * | 2008-02-11 | 2009-08-13 | Svetislav Mikalacki | Herbal cream or oil for the treatment hemorroids and wounds |
ITUD20100112A1 (it) * | 2010-06-09 | 2011-12-10 | Farma Derma S R L | Preparazione per uso vaginale e rettale e relativo procedimento di produzione |
CN102084963A (zh) * | 2010-09-29 | 2011-06-08 | 吉林省农业机械研究院 | 一种制备燕麦麦麸膳食纤维食品的方法 |
-
2012
- 2012-01-30 JP JP2014553861A patent/JP5903505B2/ja active Active
- 2012-01-30 CA CA2863369A patent/CA2863369C/fr active Active
- 2012-01-30 KR KR1020147024430A patent/KR101599447B1/ko not_active IP Right Cessation
- 2012-01-30 CN CN201910159524.8A patent/CN109865000A/zh active Pending
- 2012-01-30 RS RS20140405A patent/RS53457B/en unknown
- 2012-01-30 BR BR112014018850A patent/BR112014018850A8/pt not_active IP Right Cessation
- 2012-01-30 ES ES12716670.0T patent/ES2485490T3/es active Active
- 2012-01-30 PL PL12716670T patent/PL2646039T3/pl unknown
- 2012-01-30 RU RU2014129391/15A patent/RU2580622C2/ru not_active IP Right Cessation
- 2012-01-30 MX MX2014009244A patent/MX336204B/es unknown
- 2012-01-30 DK DK12716670.0T patent/DK2646039T3/da active
- 2012-01-30 EP EP12716670.0A patent/EP2646039B1/fr active Active
- 2012-01-30 IN IN1733MUN2014 patent/IN2014MN01733A/en unknown
- 2012-01-30 AU AU2012368815A patent/AU2012368815B2/en active Active
- 2012-01-30 WO PCT/IT2012/000027 patent/WO2013114410A1/fr active Application Filing
- 2012-01-30 SI SI201230046T patent/SI2646039T1/sl unknown
- 2012-01-30 CN CN201280068454.1A patent/CN104114177A/zh active Pending
- 2012-01-30 US US14/359,504 patent/US9345747B2/en active Active
- 2012-01-30 SG SG11201404413UA patent/SG11201404413UA/en unknown
-
2013
- 2013-01-25 TW TW102102852A patent/TWI495476B/zh not_active IP Right Cessation
- 2013-01-27 SA SA113340239A patent/SA113340239B1/ar unknown
- 2013-12-10 HK HK13113705.4A patent/HK1186378A1/xx not_active IP Right Cessation
-
2014
- 2014-06-26 HR HRP20140594AT patent/HRP20140594T1/hr unknown
- 2014-07-16 ZA ZA2014/05208A patent/ZA201405208B/en unknown
- 2014-07-30 IL IL233875A patent/IL233875A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216176A1 (zh) | 用於治療增殖性和自身免疫疾病的非對稱吡咯並苯並二氮雜卓二聚物 | |
IL236616B (en) | 5-aminotetrahydroquinoline-2-carboxylic acids and their use | |
IL234628A0 (en) | Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs | |
HK1203493A1 (en) | Substituted azabicycles and use thereof | |
EP2927281A4 (fr) | Composition de résine et ses utilisations | |
EP2828258A4 (fr) | Nouveaux dérivés de pyridopyrimidine et leur utilisation | |
GB201120993D0 (en) | Novel compounds and their use in therapy | |
HK1214274A1 (zh) | 用於治療肝臟疾病和心血管疾病的脂肽 | |
EP2922536A4 (fr) | Utilisation de bucillamine dans le traitement de la goutte | |
HK1217688A1 (zh) | -氯- 苯基- -茚- -酮及其用途 | |
HK1203198A1 (en) | Substituted phenylimidazopyrazoles and use thereof | |
IL233875A0 (en) | A preparation and its use for the treatment of anal fissures | |
EP2817304A4 (fr) | Composés inédits et leur utilisation thérapeutique | |
GB201222455D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease | |
HK1209639A1 (en) | Gpbp-1 inhibition and its therapeutic use gpbp-1 | |
EP2744786A4 (fr) | 2-imidazolidinones et 2-imidazolones substituées et leur utilisation dans le traitement du cancer | |
GB201308753D0 (en) | Compounds and their use in therapy | |
ZA201503266B (en) | Pyidone derivatives and uses thereof in the treatment of tuberculosis | |
ZA201405910B (en) | Use of modafinil in the treatment of cocaine addicts | |
ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
PL2895751T3 (pl) | Śruba i jej zastosowanie | |
HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- | |
LT2863932T (lt) | Kompozicija, skirta naudoti limfedemos gydymui | |
HUE048382T2 (hu) | 6-klór-3-(fenil-d5)-inden-1-on és alkalmazása | |
GB201308217D0 (en) | Compounds and their use in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180130 |